Français
ItalianoBond Bristol Myers-Squibb 2.35% ( US110122DR63 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price |  70.854 % ▼ |
| Country |  United States
|
| ISIN code |
 US110122DR63 ( in USD )
|
| Interest rate | 2.35% per year ( payment 2 times a year) |
| Maturity | 12/11/2040 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | / |
| Total amount | / |
| Cusip | 110122DR6 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 13/05/2026 ( In 95 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US110122DR63 bond, a USD-denominated A2 (Moody's) / A (S&P) rated instrument maturing on 12/11/2040, currently trades at 69.281% of par value with a 2.35% coupon rate paid semi-annually. |